SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Corsini E. M.)
 

Search: WFRF:(Corsini E. M.) > Risk-reducing salpi...

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Mavaddat, N (author)
Antoniou, AC (author)
Mooij, TM (author)
show more...
Hooning, MJ (author)
Heemskerk-Gerritsen, BA (author)
Nogues, C (author)
Laborde, L (author)
Breysse, E (author)
Stoppa-Lyonnet, D (author)
Gauthier-Villars, M (author)
Buecher, B (author)
Caron, O (author)
Fourme-Mouret, E (author)
Fricker, JP (author)
Lasset, C (author)
Bonadona, V (author)
Berthet, P (author)
Faivre, L (author)
Luporsi, E (author)
Mari, V (author)
Gladieff, L (author)
Gesta, P (author)
Sobol, H (author)
Eisinger, F (author)
Nogues, C (author)
Longy, M (author)
Dugast, C (author)
Colas, C (author)
Coupier, I (author)
Pujol, P (author)
Corsini, C (author)
Lortholary, A (author)
Vennin, P (author)
Adenis, C (author)
Nguyen, TD (author)
Delnatte, C (author)
Tinat, J (author)
Tennevet, I (author)
Limacher, JM (author)
Maugard, C (author)
Bignon, YJ (author)
Demange, L (author)
Penet, C (author)
Dreyfus, H (author)
Cohen-Haguenauer, O (author)
Venat-Bouvet, L (author)
Leroux, D (author)
Zattara-Cannoni, H (author)
Fert-Ferrer, S (author)
Bera, O (author)
Nogues, C (author)
Gauthier-Villars, M (author)
Caron, O (author)
Gesta, P (author)
Pujol, P (author)
Lortholary, A (author)
Ellis, S (author)
Ellis, S (author)
Barrowdale, D (author)
Frost, D (author)
Evans, DG (author)
Izatt, L (author)
Adlard, J (author)
Eeles, R (author)
Brewer, C (author)
Tischkowitz, M (author)
Henderson, A (author)
Cook, J (author)
Eccles, D (author)
Hogervorst, FBL (author)
Hogervorst, FBL (author)
Collee, JM (author)
van Asperen, CJ (author)
Mensenkamp, AR (author)
Ausems, MGEM (author)
Meijers-Heijboer, HEJ (author)
van Engelen, K (author)
Blok, MJ (author)
Oosterwijk, JC (author)
Verloop, J (author)
van den Broek, E (author)
van Engelen, K (author)
Mourits, MJE (author)
Ausems, MGEM (author)
Koppert, LB (author)
Hopper, JL (author)
John, EM (author)
Chung, WK (author)
Andrulis, IL (author)
Daly, MB (author)
Buys, SS (author)
Benitez, J (author)
Caldes, T (author)
Jakubowska, A (author)
Simard, J (author)
Singer, CF (author)
Tan, Y (author)
Olah, E (author)
Navratilova, M (author)
Foretova, L (author)
Gerdes, AM (author)
Roos-Blom, MJ (author)
Van Leeuwen, FE (author)
Arver, B (author)
Olsson, H (author)
Schmutzler, RK (author)
Engel, C (author)
Kast, K (author)
Phillips, KA (author)
Terry, MB (author)
Milne, RL (author)
Goldgar, DE (author)
Rookus, MA (author)
Andrieu, N (author)
Easton, DF (author)
show less...
2020-01-16
2020
English.
In: Breast cancer research : BCR. - : Springer Science and Business Media LLC. - 1465-542X. ; 22:1, s. 8-
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BackgroundThe effect of risk-reducing salpingo-oophorectomy (RRSO) on breast cancer risk forBRCA1andBRCA2mutation carriers is uncertain. Retrospective analyses have suggested a protective effect but may be substantially biased. Prospective studies have had limited power, particularly forBRCA2mutation carriers. Further, previous studies have not considered the effect of RRSO in the context of natural menopause.MethodsA multi-centre prospective cohort of 2272BRCA1and 1605BRCA2mutation carriers was followed for a mean of 5.4 and 4.9 years, respectively; 426 women developed incident breast cancer. RRSO was modelled as a time-dependent covariate in Cox regression, and its effect assessed in premenopausal and postmenopausal women.ResultsThere was no association between RRSO and breast cancer forBRCA1(HR = 1.23; 95% CI 0.94–1.61) orBRCA2(HR = 0.88; 95% CI 0.62–1.24) mutation carriers. ForBRCA2mutation carriers, HRs were 0.68 (95% CI 0.40–1.15) and 1.07 (95% CI 0.69–1.64) for RRSO carried out before or after age 45 years, respectively. The HR forBRCA2mutation carriers decreased with increasing time since RRSO (HR = 0.51; 95% CI 0.26–0.99 for 5 years or longer after RRSO). Estimates for premenopausal women were similar.ConclusionWe found no evidence that RRSO reduces breast cancer risk forBRCA1mutation carriers. A potentially beneficial effect forBRCA2mutation carriers was observed, particularly after 5 years following RRSO. These results may inform counselling and management of carriers with respect to RRSO.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view